Compugen Ltd

Compugen Exec Levine Zurit Trades 11,875 Shares on Rule 10b5‑1 Plan Amid 15% Monthly Rally, Signaling Disciplined Insider Activity

Levine Zurit’s disciplined 10b5‑1 trades show Compugen’s exec buying low and selling high, boosting investor confidence in the company’s rising biotech outlook.

Compugen Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

09/04/2026, 22:38

3 minutes to read

Compugen Execs Trade Their Own Stock, Yet Confidence Grows Amid Sky‑High Gains

Insider trades by Compugen SVP and CEO reveal disciplined buying‑selling patterns that align with the company’s sharp price gains, hinting at sustained confidence in its oncology genomics platform.

Compugen Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/04/2026, 13:47

3 minutes to read